Suppr超能文献

直流电复律后维持窦性心律的新型药物干预措施。

Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.

作者信息

Thomas D E, Yousef Z, Anderson R A

机构信息

The Department of Cardiology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN Wales, UK.

出版信息

ISRN Cardiol. 2011;2011:176834. doi: 10.5402/2011/176834. Epub 2011 Jul 12.

Abstract

Despite the availability of potentially curative interventions for atrial fibrillation, there remains an important role for conventional anti-arrhythmic therapy and anti-coagulation combined with direct current cardioversion. Unfortunately, the latter approach is disturbed by high recurrence rates of atrial fibrillation. In recent years, several adjunctive therapies have emerged which may facilitate the maintenance of sinus rhythm. These novel therapies and their potential mechanisms of action are reviewed in this article.

摘要

尽管有针对心房颤动的潜在治愈性干预措施,但传统抗心律失常治疗以及抗凝与直流电复律相结合仍发挥着重要作用。不幸的是,后一种方法受到心房颤动高复发率的干扰。近年来,出现了几种辅助治疗方法,可能有助于维持窦性心律。本文对这些新疗法及其潜在作用机制进行了综述。

相似文献

1
Novel Pharmacological Interventions to Maintain Sinus Rhythm after DC Cardioversion.
ISRN Cardiol. 2011;2011:176834. doi: 10.5402/2011/176834. Epub 2011 Jul 12.
5
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003.
8
High maintenance rate of sinus rhythm after cardioversion in post-thyrotoxic chronic atrial fibrillation.
Int J Cardiol. 1987 Jul;16(1):47-55. doi: 10.1016/0167-5273(87)90269-5.
9
CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.
J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):636-41. doi: 10.2459/JCM.0000000000000139.
10
[Pharmacological therapy of atrial fibrillation and atrial flutter].
Herz. 2002 Jun;27(4):329-44. doi: 10.1007/s00059-002-2390-7.

本文引用的文献

1
Valsartan for prevention of recurrent atrial fibrillation.
N Engl J Med. 2009 Apr 16;360(16):1606-17. doi: 10.1056/NEJMoa0805710.
4
Candesartan in the prevention of relapsing atrial fibrillation.
Int J Cardiol. 2007 Aug 9;120(1):85-91. doi: 10.1016/j.ijcard.2006.08.086. Epub 2006 Nov 17.
6
Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure.
J Cardiovasc Electrophysiol. 2006 May;17(5):534-41. doi: 10.1111/j.1540-8167.2006.00372.x.
7
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction.
Eur Heart J. 2005 Oct;26(20):2193-9. doi: 10.1093/eurheartj/ehi478. Epub 2005 Sep 1.
8
Mechanism for atrial tachyarrhythmia in chronic volume overload-induced dilated atria.
J Cardiovasc Electrophysiol. 2005 Jul;16(7):760-9. doi: 10.1046/j.1540-8167.2005.40331.x.
10
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.
J Am Coll Cardiol. 2005 Apr 19;45(8):1243-8. doi: 10.1016/j.jacc.2005.01.015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验